Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab + XELOX in Advanced Gastric Cancer
NCT00398398Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Nov 2006
- Primary completion
- Sep 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in gastric cancer (GC), sponsored by Asan Medical Center. Started Nov 2006; status: completed.
02
Drugs
KL-140
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00398398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00398398.